The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
12 11 2022
Historique:
received: 01 02 2022
accepted: 31 10 2022
entrez: 13 11 2022
pubmed: 14 11 2022
medline: 16 11 2022
Statut: epublish

Résumé

Superoxide dismutase (SOD1) gene variants may cause amyotrophic lateral sclerosis, some of which are associated with a distinct phenotype. Most studies assess limited variants or sample sizes. In this international, retrospective observational study, we compare phenotypic and demographic characteristics between people with SOD1-ALS and people with ALS and no recorded SOD1 variant. We investigate which variants are associated with age at symptom onset and time from onset to death or censoring using Cox proportional-hazards regression. The SOD1-ALS dataset reports age of onset for 1122 and disease duration for 883 people; the comparator population includes 10,214 and 9010 people respectively. Eight variants are associated with younger age of onset and distinct survival trajectories; a further eight associated with younger onset only and one with distinct survival only. Here we show that onset and survival are decoupled in SOD1-ALS. Future research should characterise rarer variants and molecular mechanisms causing the observed variability.

Identifiants

pubmed: 36371497
doi: 10.1038/s41467-022-34620-y
pii: 10.1038/s41467-022-34620-y
pmc: PMC9653399
doi:

Substances chimiques

Superoxide Dismutase-1 EC 1.15.1.1
Superoxide Dismutase EC 1.15.1.1
SOD1 protein, human 0

Types de publication

Observational Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6901

Subventions

Organisme : NINDS NIH HHS
ID : R56 NS073873
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS073873
Pays : United States
Organisme : Medical Research Council
ID : MR/R024804/1
Pays : United Kingdom
Organisme : Motor Neurone Disease Association
ID : MCLAUGHLIN/OCT15/957-799
Pays : United Kingdom
Organisme : Motor Neurone Disease Association
ID : ALCHALABI-DOBSON/APR14/829-791
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Transl Neurodegener. 2019 Jan 08;8:2
pubmed: 30637102
Eur J Epidemiol. 2016 Mar;31(3):229-45
pubmed: 26458931
Transl Neurodegener. 2016 Feb 03;5:3
pubmed: 26843957
Neurol Genet. 2018 May 18;4(3):e239
pubmed: 29845113
Neurology. 2018 Aug 14;91(7):e635-e642
pubmed: 30045958
Lancet Neurol. 2014 Nov;13(11):1108-1113
pubmed: 25300936
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):268-271
pubmed: 30270202
Clin Genet. 2017 Sep;92(3):259-266
pubmed: 28105640
Hum Hered. 2011;71(4):281-8
pubmed: 21846995
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):10934-9
pubmed: 23781106
NPJ Genom Med. 2020 Aug 7;5:32
pubmed: 32789025
N Engl J Med. 2020 Jul 9;383(2):109-119
pubmed: 32640130
Hum Mutat. 2002 Dec;20(6):473
pubmed: 12442272
Hum Mutat. 2012 Sep;33(9):1345-51
pubmed: 22753137
Curr Opin Neurol. 2008 Dec;21(6):693-700
pubmed: 18989115
J Neurol. 2009 Feb;256(2):234-41
pubmed: 19252762
Eur J Hum Genet. 2018 Oct;26(10):1537-1546
pubmed: 29955173
Lancet Neurol. 2010 Oct;9(10):986-94
pubmed: 20801717
Arch Biochem Biophys. 2009 Dec;492(1-2):40-7
pubmed: 19800308
Nature. 1993 Mar 4;362(6415):59-62
pubmed: 8446170
Neurology. 2017 Oct 31;89(18):1915-1922
pubmed: 28978660
Nat Rev Neurosci. 2021 Aug;22(8):515
pubmed: 34103711
Nat Rev Neurosci. 2021 Aug;22(8):514
pubmed: 34103710
Nat Genet. 2016 Sep;48(9):1043-8
pubmed: 27455348
J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):99-105
pubmed: 27261500
Am J Hum Genet. 2016 Feb 4;98(2):287-98
pubmed: 26849111
Arch Neurol. 2012 Sep;69(9):1159-63
pubmed: 22964911
J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):537
pubmed: 28209650
Ann Neurol. 1998 Mar;43(3):390-4
pubmed: 9506558
Nat Rev Neurol. 2014 Jun;10(6):337-48
pubmed: 24840975
J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):540-549
pubmed: 28057713

Auteurs

Sarah Opie-Martin (S)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.

Alfredo Iacoangeli (A)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.
Department of Biostatistics and Health Informatics, Institute of Psychiatry Psychology & Neuroscience, King's College London, SE5 8AF, London, UK.
NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.

Simon D Topp (SD)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.

Olubunmi Abel (O)

Homerton University Hospital, Homerton Row, London, E9 6SR, UK.

Keith Mayl (K)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.

Puja R Mehta (PR)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.

Aleksey Shatunov (A)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.
Department of Molecular and Clinical Pharmacology, University of Liverpool, Blue Block 1.09, Sherrington Building, Crown St, Liverpool, L693BX, UK.
Institute of Medicine, North-Eastern Federal University, 58 Belinsky str, Yakutsk, 677000, Russia.

Isabella Fogh (I)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.

Harry Bowles (H)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.

Naomi Limbachiya (N)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.

Thomas P Spargo (TP)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.

Ahmad Al-Khleifat (A)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.

Kelly L Williams (KL)

Macquarie University Centre for MND Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.

Jennifer Jockel-Balsarotti (J)

Department of Neurology, Washington University School of Medicine, St Louis, MO, 63110, USA.

Taha Bali (T)

Department of Neurology, Washington University School of Medicine, St Louis, MO, 63110, USA.

Wade Self (W)

Department of Neurology, Washington University School of Medicine, St Louis, MO, 63110, USA.

Lyndal Henden (L)

Macquarie University Centre for MND Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.

Garth A Nicholson (GA)

Macquarie University Centre for MND Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.
Concord Clinical School, ANZAC Research Institute, Concord Repatriation Hospital, Sydney, NSW, 2139, Australia.

Nicola Ticozzi (N)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, 20095, Cusano Milanino, MiIan, Italy.
Dino Ferrari Center, Department of Pathophysiology and Transplantation, Center for Neurotechnology and Brain Therapeutics, Università degli Studi di Milano, Milan, Italy.

Diane McKenna-Yasek (D)

Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 02125, USA.

Lu Tang (L)

Department of Neurology, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, PR China.

Pamela J Shaw (PJ)

Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, S10 2HQ, UK.

Adriano Chio (A)

Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
Neurology 1, AOU Città della Salute e della Scienza of Torino, Turin, 10124, Torino, Italy.

Albert Ludolph (A)

Department of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany.
German Center for Neurodegenerative Diseases, DZNE, Ulm, Germany.

Jochen H Weishaupt (JH)

Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081, Ulm, Germany.
Division of Neurodegenerative Disorders, Department of Neurology, Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.

John E Landers (JE)

Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 02125, USA.

Jonathan D Glass (JD)

Department Neurology, Emory University School of Medicine, Atlanta, GA, 30322, USA.

Jesus S Mora (JS)

ALS Unit, Department of Neurology, Hospital San Rafael, 28016, Madrid, Spain.

Wim Robberecht (W)

Neurology Department, Univeristy Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.

Philip Van Damme (PV)

Neurology Department, Univeristy Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.
Neuroscience Department, KU Leuven and Center for Brain & Disease Research VIB Leuven, Leuven, Belgium.

Russell McLaughlin (R)

Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Dublin, D02 PN40, Ireland.

Orla Hardiman (O)

Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, D02 PN40, Ireland.

Leonard van den Berg (L)

Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands.

Jan H Veldink (JH)

Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands.

Phillippe Corcia (P)

Centre de Référence pour la SLA et les Autres Maladies du Motoneurone (FILSLAN), 2 Avenue Martin Luther King, 87042, Limoges Cedex, France.
Centre de Compétences Neuropathies Amyloïdes Familiales et Autres Neuropathies Périphériques Rares (NNERF), Poitiers, France.

Zorica Stevic (Z)

Neurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Studentski trg 1, Belgrade, Serbia.

Nailah Siddique (N)

Neuromuscular Disorders Program, Northwestern University, Feinberg School of Medicine, Chicago, IL, 60208, USA.

Vincenzo Silani (V)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, 20095, Cusano Milanino, MiIan, Italy.
Dino Ferrari Center, Department of Pathophysiology and Transplantation, Center for Neurotechnology and Brain Therapeutics, Università degli Studi di Milano, Milan, Italy.

Ian P Blair (IP)

Macquarie University Centre for MND Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.

Dong-Sheng Fan (DS)

Department of Neurology, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, PR China.

Florence Esselin (F)

Reference Center for ALS and Other Rare Motoneuron Disorders, University Hospital Gui de Chauliac, 34295, Montpellier, France.

Elisa de la Cruz (E)

Reference Center for ALS and Other Rare Motoneuron Disorders, University Hospital Gui de Chauliac, 34295, Montpellier, France.

William Camu (W)

Reference Center for ALS and Other Rare Motoneuron Disorders, University Hospital Gui de Chauliac, 34295, Montpellier, France.

Nazli A Basak (NA)

Koç University, School of Medicine Translational Medicine Research Center KUTTAM-NDAL, 34450, Sarıyer, Istanbul, Turkey.

Teepu Siddique (T)

Neuromuscular Disorders Program, Northwestern University, Feinberg School of Medicine, Chicago, IL, 60208, USA.

Timothy Miller (T)

Department of Neurology, Washington University School of Medicine, St Louis, MO, 63110, USA.

Robert H Brown (RH)

Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 02125, USA.

Ammar Al-Chalabi (A)

Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 9NU, UK.

Christopher E Shaw (CE)

UK Dementia Research Institute Centre at King's College London, School of Neuroscience, King's College London, Strand, London, WC2R 2LS, UK. chris.shaw@kcl.ac.uk.
Centre for Brain Research, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand. chris.shaw@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH